In the evolving landscape of prostate disease treatment, Sonablate® HIFU stands out as the world’s most advanced and trusted focal therapy platform.

Unmatched Clinical Experience & Outcomes

Sonablate® has been validated in 5.5 times more patients and with 3.8 times longer follow-up compared to other systems, demonstrating:

• Higher failure-free survival (91–98%)
• Fewer salvage procedures needed
• Lower incidence of clinically significant disease detected on follow-up
• Excellent preservation of continence and sexual function

These outcomes speak volumes – especially when treating patients with higher-risk disease.

The Most Advanced Treatment Technology

Sonablate® offers features simply not available with other HIFU systems:

• Adaptive dosing and real-time monitoring of tissue change and reflectivity index
• Customisable automatic planning margins to protect critical structures
• Detection of prostate movement in real time
• Reference ultrasound imaging for precise intraoperative assessment

This translates into a platform designed for precision, safety, and confidence – every procedure.

Optimised for Patient Quality of Life

Sonablate® enables:

• Driving the next day
• Early return to work and daily activities
• Detection of prostate movement in real time

Trusted by the World’s Leading Urologists

With over 20,000 hours of dedicated tech support and more than 5,000 hours of dedicated nursing experience, Sonablate® has become the preferred system among clinicians who demand the very best for their patients.

• Cerno Health is now inviting more Urologists to come onboard

If you are a Urologist interested in setting up a focal therapy service in your practice or hospital, contact Cerno Health today to learn more.

Together, we can make world-class, minimally invasive care accessible to more patients.